Who Owns Integral Diagnostics Company?

Integral Diagnostics Bundle

Get Full Bundle:

	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

Who Owns Integral Diagnostics?

Understanding the ownership of Integral Diagnostics is key to grasping its market position and future plans. This Australian diagnostic imaging leader operates a wide network of clinics, offering essential services like MRI and CT scans. Its strategic direction is significantly influenced by its shareholder base.

Integral Diagnostics, a major player in medical imaging, has a history shaped by its growth and recent corporate actions. As of August 14, 2025, its market capitalization stood at $657 million, with 372 million shares outstanding. The company's financial performance, including a trailing 12-month revenue of $324 million as of December 31, 2024, underpins its valuation and ownership dynamics.

The ownership structure of Integral Diagnostics is dynamic, particularly with the proposed merger with Capitol Health. This event is expected to reshape its shareholder profile and influence its strategic trajectory. For a deeper understanding of the external factors affecting the company, consider an Integral Diagnostics PESTEL Analysis.

Integral Diagnostics Limited, established in either 2002 or 2008 in Melbourne, Australia, has a history that includes the formation of key entities like Lake Imaging in 2002 and the practice that became South Coast Radiology in 1967. While the specific founders and their initial equity stakes are not detailed in recent public reports, the company's trajectory involved significant private equity backing prior to its public listing.

Company Origins Integral Diagnostics was founded in Australia, with its roots tracing back to Melbourne. The company's establishment period is noted as either 2002 or 2008. Key Predecessors The company's history is linked to the establishment of Lake Imaging in 2002 and the practice that evolved into South Coast Radiology, founded in 1967. Merger Activity A significant development was the merger of South Coast Radiology with Integral Diagnostics in 2014, consolidating operations. Private Equity Involvement Prior to its public offering, Integral Diagnostics was backed by private equity. This indicates early investment and influence from private equity firms. Public Listing Integral Diagnostics successfully completed its Initial Public Offering (IPO) and listed on the Australian Securities Exchange (ASX) in 2015. Founder Details Specific details regarding the individual founders, their backgrounds, and the initial equity distribution at the company's inception are not extensively detailed in publicly available recent reports.

The early ownership structure of Integral Diagnostics was significantly shaped by private equity investment before its public debut. This private equity backing would have been instrumental in the company's foundational stages and subsequent growth, though the specific firms and their initial stakes are not publicly disclosed in current data. Understanding this early phase is key to grasping the overall Integral Diagnostics ownership landscape.

Integral Diagnostics Ownership Evolution

The journey of Integral Diagnostics from its inception to becoming a publicly traded entity involved strategic growth and structural changes, including private equity involvement and key mergers. This evolution directly impacts who owns Integral Diagnostics today.

• The company's origins are in Melbourne, Australia.
• Key historical entities include Lake Imaging and South Coast Radiology.
• A significant merger occurred in 2014 with South Coast Radiology.
• Integral Diagnostics was formerly PE-backed before its ASX listing in 2015.
• Detailed founder information and initial equity splits are not readily available in recent public disclosures.
• The Marketing Strategy of Integral Diagnostics has likely played a role in its growth and investor appeal.

Integral Diagnostics SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

Integral Diagnostics (ASX: IDX) has seen its ownership evolve significantly since its 2015 ASX listing, most notably with a major acquisition in late 2024. This strategic move reshaped the distribution of ownership among its stakeholders.

Prior to the significant merger, individual investors held the largest portion of Integral Diagnostics' shares, representing 58% of the company's ownership as of October 3, 2023. Institutional investors held a substantial 32% stake. Among these institutional holders, Yarra Funds Management Limited was the most significant, with a 6.7% shareholding. Other key institutional investors included The Vanguard Group, Inc., State Street Global Advisors, Inc., Viburnum Funds Pty Ltd, Perennial Value Management Ltd, and Investors Mutual Ltd, with holdings around 6.1% and 5.5% respectively.

Post-Merger Ownership Landscape

The acquisition of Capitol Health Limited, completed on December 11, 2024, fundamentally altered the ownership structure. This strategic integration is expected to yield substantial cost synergies.

• Integral Diagnostics acquired 100% of Capitol Health.
• Existing Integral Diagnostics shareholders are projected to hold approximately 63% of the combined entity.
• Former Capitol Health shareholders will own the remaining 37%.
• The merger expanded the network to 155 diagnostic imaging sites.
• Expected annual pre-tax net cost synergies of at least $10.0 million.

The merger with Capitol Health Limited, finalized on December 11, 2024, marked a pivotal moment for Integral Diagnostics' ownership. This transaction, valued at approximately AUD 350 million, saw Integral Diagnostics absorb Capitol Health. Following this integration, the ownership balance is set to shift, with current Integral Diagnostics shareholders anticipated to collectively own about 63% of the enlarged company. The former shareholders of Capitol Health will then hold the remaining 37%. This strategic consolidation, which added 60 clinics to Integral Diagnostics' existing 70, aims to deliver significant operational efficiencies, with projections of at least $10.0 million in annual pre-tax net cost synergies. Understanding these shifts is crucial for grasping the current Integral Diagnostics ownership and who owns Integral Diagnostics moving forward.

Integral Diagnostics PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

Integral Diagnostics' Board of Directors is structured to oversee the company's strategic direction and operations. As of its 2024 Annual Report, the board includes key leadership figures and independent directors, ensuring diverse perspectives in governance.

The voting power within Integral Diagnostics generally adheres to the standard one-share-one-vote principle common among publicly listed entities. While the company has implemented a Loan Share Plan for radiologists, offering them loans to acquire shares, these arrangements are designed to align interests without granting disproportionate voting control. These LTI Rights do not confer dividends or voting rights prior to vesting. Following the merger with Capitol Health, the board composition is set to expand with the addition of two independent directors from Capitol Health, enhancing its governance framework.

Board and Shareholder Dynamics

The board's composition and voting power are central to Integral Diagnostics' governance. Understanding these structures is key to grasping the company's ownership dynamics.

• The board is comprised of executive and independent non-executive directors.
• Voting rights are typically tied to ordinary shares on a one-share-one-vote basis.
• Share plans for radiologists are structured to acknowledge their role without altering fundamental voting control.
• The recent merger with Capitol Health will introduce new independent directors to the board.
• There have been no significant proxy battles or activist campaigns reported for the 2024-2025 period.

Integral Diagnostics Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Integral Diagnostics has undergone a significant transformation in its ownership structure over the past few years, most notably with its merger with Capitol Health Limited. This strategic move, finalized in December 2024, has reshaped the company's shareholder base and operational scale.

The merger with Capitol Health Limited, valued at approximately AUD 350 million, was a pivotal event, completed on December 11, 2024. This transaction led to a substantial increase in the total shares outstanding by 59.1% due to equity issuance. Institutional investors maintain a strong presence, with key holders including Yarra Funds Management Limited (6.7%), The Vanguard Group, Inc., and State Street Global Advisors, Inc. As of December 31, 2024, the company reported 8,777 shareholders. The net debt rose to $298.7 million in 1H FY25, partly due to assuming Capitol Health's debt, resulting in a net debt to equity ratio of 43.1%. Integral Diagnostics is also navigating a legal claim from vendors of the Imaging Queensland business concerning an earn-out valuation dispute, which the company plans to contest.

Merger Impact on Ownership

The merger with Capitol Health has significantly altered the Integral Diagnostics ownership landscape. Integral Diagnostics shareholders now hold a majority stake of 63% in the combined entity.

Key Institutional Investors

Major institutional investors continue to be significant Integral Diagnostics shareholders. Yarra Funds Management Limited holds 6.7%, alongside substantial holdings by The Vanguard Group, Inc. and State Street Global Advisors, Inc.

Shareholder Growth and Dilution

The total shares outstanding for Integral Diagnostics saw a 59.1% increase in the past year. This growth is primarily attributed to the equity issued as part of the Capitol Health acquisition, impacting the overall shareholding breakdown.

Financial Position Post-Merger

Integral Diagnostics' net debt increased by $88.7 million to $298.7 million in 1H FY25. The net debt to equity ratio stands at 43.1%, reflecting the financial integration following the merger and its Competitors Landscape of Integral Diagnostics.

Integral Diagnostics Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔